Supplementary protection certificates: where are we and where are we going? (an update)
February 2019
In this webinar, Matthew Royle, Judith Krens and Verena Bertram provide an overview of the current status of supplementary protection certificate law in Europe and the impact of the latest decisions of the Court of Justice of the European Union.
If you have any questions on this article or would like to propose a subject to be addressed by Synapse please contact us.
Latest topical issues
SPC manufacturing waiver for export 
Falsified Medicine Directive continued
SPC for ezetimibe/simvastatin considered invalid
Previous articles
Clinical trial liability – navigating the legal, regulatory and insurance landscape
Biosimilars – interchangeability / substitution and advertising
